ASCO 2019: Women Don't Need Reminders to Take Aromatase Inhibitors, They Need Better Treatments for Side Effects

Audio

Description

A member of the Breastcancer.org Professional Advisory Board, Dr. Dawn Hershman leads the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, where she is professor of medicine and epidemiology. Dr. Hershman is a nationally recognized expert in breast cancer treatment, prevention, and survivorship. ' At this ASCO annual meeting, Dr. Hershman presented results from a study looking at whether text messaging could increase the number of women who stick to their aromatase inhibitor treatment plans. Listen to the podcast to hear Dr. Hershman talk about: the background of the study the study results, which showed no difference in treatment adherence between women who received text messages and women who didn't what future research needs to do to better help women stick to their aromatase inhibitor treatment plans

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Breastcancer.org Podcast

This episode hasn't been transcribed yet

Other recent transcribed episodes

3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE

13:00H | 21 DIC 2025 | Fin de Semana

12:00H | 21 DIC 2025 | Fin de Semana

10:00H | 21 DIC 2025 | Fin de Semana

13:00H | 20 DIC 2025 | Fin de Semana

12:00H | 20 DIC 2025 | Fin de Semana

Sign in to Audioscrape

Share this moment